{"sourcedb":"DevicePMAs@therightstef","sourceid":"P030025_S086","text":"Approval to expand the labeled indications for the taxus express2 paclitaxel-eluting coronary stent system.  The taxus express2 paclitaxel-eluting coronary stent system is indicated for improving luminal diameter: 1) for the treatment of de novo lesions in native coronary arteries 2.25 mm to 4.00 mm in diameter in lesions\u003C= 28 mm in length; 2) in patients undergoing primary angioplasty to treat acute st-segment elevation myocardial infarction, true posterior myocardial infarction, or presumed new left bundle branch block with symptoms of acute myocardial infarction lasting \u003E 20 minutes and \u003C 12 hours in duration; or 3) within bare metal stent restenotic lesions 2.50 mm to 3.75 mm in diameter and \u003C= 28 mm in length.","project":"consensus_PMA_Age_Indications"}